Skip to main content
Study links metformin to better survival in veterans with CKD

A study in the Journal of General Internal Medicine found initial monotherapy with metformin, instead of a sulfonylurea, was associated with a lower mortality risk for up to six years among veterans who developed type 2 diabetes, regardless of whether they had normal or mild to moderately impaired kidney function. The findings were based on data from the Veterans Health Administration for 175,296 patients.

Full Story: